These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

90 related articles for article (PubMed ID: 37778903)

  • 21. Reduced humoral response 3 months following BNT162b2 vaccination in SARS-CoV-2 uninfected residents of long-term care facilities.
    Trigueros M; Pradenas E; Palacín D; Muñoz-López F; Ávila-Nieto C; Trinité B; Bonet-Simó JM; Isnard M; Moreno N; Marfil S; Rovirosa C; Puig T; Grau E; Chamorro A; Martinez A; Toledo R; Font M; Ara J; Carrillo J; Mateu L; Blanco J; Clotet B; Prat N; Massanella M;
    Age Ageing; 2022 May; 51(5):. PubMed ID: 35595256
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Estimating the infection-fatality risk of SARS-CoV-2 in New York City during the spring 2020 pandemic wave: a model-based analysis.
    Yang W; Kandula S; Huynh M; Greene SK; Van Wye G; Li W; Chan HT; McGibbon E; Yeung A; Olson D; Fine A; Shaman J
    Lancet Infect Dis; 2021 Feb; 21(2):203-212. PubMed ID: 33091374
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Considerations on older adults health status during COVID-19.
    Garamende-Gutiérrez DY; Nolasco-Ramos GM; Llanco-Albornoz LA
    Gac Med Mex; 2021; 157(5):554. PubMed ID: 35104272
    [No Abstract]   [Full Text] [Related]  

  • 24. Dynamic IgG seropositivity after rollout of CoronaVac and BNT162b2 COVID-19 vaccines in Chile: a sentinel surveillance study.
    Sauré D; O'Ryan M; Torres JP; Zuniga M; Santelices E; Basso LJ
    Lancet Infect Dis; 2022 Jan; 22(1):56-63. PubMed ID: 34509185
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Comparing Fear of COVID-19 and Preventive COVID-19 Infection Behaviors Between Iranian and Taiwanese Older People: Early Reaction May Be a Key.
    Pakpour AH; Liu CH; Hou WL; Chen YP; Li YP; Kuo YJ; Lin CY; Scarf D
    Front Public Health; 2021; 9():740333. PubMed ID: 34631652
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Long-term quantitative assessment of anti-SARS-CoV-2 spike protein immunogenicity (QUASI) after COVID-19 vaccination in older people living with HIV (PWH).
    Tuan JJ; Zapata H; Barakat L; Andrews L; Behnegar A; Kim YW; Kayani J; Mutic S; Ryall L; Turcotte B; Critch-Gilfillan T; Zhao M; Salahuddin S; Gupta S; Sutton R; Friedland G; Emu B; Ogbuagu O
    BMC Infect Dis; 2022 Sep; 22(1):744. PubMed ID: 36131232
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Dynamic and features of SARS-CoV-2 infection in Gabon.
    Mveang Nzoghe A; Padzys GS; Maloupazoa Siawaya AC; Kandet Yattara M; Leboueny M; Avome Houechenou RM; Bongho EC; Mba-Mezeme C; Mvoundza Ndjindji O; Biteghe-Bi-Essone JC; Boulende A; Essone PN; Ndong Sima CAA; Minkobame U; Zang Eyi C; Ndeboko B; Voloc A; Meye JF; Ategbo S; Djoba Siawaya JF
    Sci Rep; 2021 May; 11(1):9672. PubMed ID: 33958601
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Vaccine effectiveness against symptomatic SARS-CoV-2 infection in adults aged 65 years and older in primary care: I-MOVE-COVID-19 project, Europe, December 2020 to May 2021.
    Kissling E; Hooiveld M; Sandonis Martín V; Martínez-Baz I; William N; Vilcu AM; Mazagatos C; Domegan L; de Lusignan S; Meijer A; Machado A; Brytting M; Casado I; Murray JK; Belhillil S; Larrauri A; O'Donnell J; Tsang R; de Lange M; Rodrigues AP; Riess M; Castilla J; Hamilton M; Falchi A; Pozo F; Dunford L; Cogdale J; Jansen T; Guiomar R; Enkirch T; Burgui C; Sigerson D; Blanchon T; Martínez Ochoa EM; Connell J; Ellis J; van Gageldonk-Lafeber R; Kislaya I; Rose AM; Valenciano M; ;
    Euro Surveill; 2021 Jul; 26(29):. PubMed ID: 34296676
    [TBL] [Abstract][Full Text] [Related]  

  • 29. SARS-CoV-2-specific immune responses in elderly and immunosuppressed participants and patients with hematologic disease or checkpoint inhibition in solid tumors: study protocol of the prospective, observational CoCo immune study.
    Dopfer-Jablonka A; Steffens S; Müller F; Mikuteit M; Niewolik J; Cossmann A; Stankov MV; Behrens GMN; Hummers E; Heesen G; Schröder D; Roder S; Klawonn F; Vahldiek K; Hasenkamp J; Kallusky J; Falk CS; Overbeck TR; Heinemann S
    BMC Infect Dis; 2022 Apr; 22(1):403. PubMed ID: 35468758
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Effect of COVID-19 vaccination on the SARS-CoV-2 transmission among social and household close contacts: A cohort study.
    Martínez-Baz I; Miqueleiz A; Egüés N; Casado I; Burgui C; Echeverría A; Navascués A; Fernández-Huerta M; García Cenoz M; Trobajo-Sanmartín C; Guevara M; Ezpeleta C; Castilla J
    J Infect Public Health; 2023 Mar; 16(3):410-417. PubMed ID: 36724697
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Pre-Vaccine Positivity of SARS-CoV-2 Antibodies in Alberta, Canada during the First Two Waves of the COVID-19 Pandemic.
    Charlton CL; Nguyen LT; Bailey A; Fenton J; Plitt SS; Marohn C; Lau C; Hinshaw D; Lutsiak C; Simmonds K; Kanji JN; Zelyas N; Lee N; Mengel M; Tipples G
    Microbiol Spectr; 2021 Sep; 9(1):e0029121. PubMed ID: 34406813
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Does the Coronavirus (COVID-19) Pandemic Call for a New Model of Older People Care?
    Palombi L; Liotta G; Orlando S; Emberti Gialloreti L; Marazzi MC
    Front Public Health; 2020; 8():311. PubMed ID: 32656176
    [No Abstract]   [Full Text] [Related]  

  • 33. Sociodemographic, clinical, and immunological factors associated with SARS-CoV-2 diagnosis and severe COVID-19 outcomes in people living with HIV: a retrospective cohort study.
    Nomah DK; Reyes-Urueña J; Díaz Y; Moreno S; Aceiton J; Bruguera A; Vivanco-Hidalgo RM; Llibre JM; Domingo P; Falcó V; Imaz A; Cortés C; Force L; Letang E; Vilaró I; Casabona J; Miro JM;
    Lancet HIV; 2021 Nov; 8(11):e701-e710. PubMed ID: 34655549
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Factors Associated With Using the COVID-19 Mobile Contact-Tracing App Among Individuals Diagnosed With SARS-CoV-2 in Amsterdam, the Netherlands: Observational Study.
    Ritsema F; Bosdriesz JR; Leenstra T; Petrignani MWF; Coyer L; Schreijer AJM; van Duijnhoven YTHP; van de Wijgert JHHM; Schim van der Loeff MF; Matser A
    JMIR Mhealth Uhealth; 2022 Aug; 10(8):e31099. PubMed ID: 35867842
    [TBL] [Abstract][Full Text] [Related]  

  • 35. COVID-19 deaths in children and young people in England, March 2020 to December 2021: An active prospective national surveillance study.
    Bertran M; Amin-Chowdhury Z; Davies HG; Allen H; Clare T; Davison C; Sinnathamby M; Seghezzo G; Kall M; Williams H; Gent N; Ramsay ME; Ladhani SN; Oligbu G
    PLoS Med; 2022 Nov; 19(11):e1004118. PubMed ID: 36346784
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Central Nervous System Effects of COVID-19 in People with HIV Infection.
    Peluso MJ; Hellmuth J; Chow FC
    Curr HIV/AIDS Rep; 2021 Dec; 18(6):538-548. PubMed ID: 34843065
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Effectiveness of booster vaccination with inactivated COVID-19 vaccines against SARS-CoV-2 Omicron BA.2 infection in Guangdong, China: a cohort study.
    He X; Zeng B; Wang Y; Pang Y; Zhang M; Hu T; Liang Y; Kang M; Tang S
    Front Immunol; 2023; 14():1257360. PubMed ID: 37915583
    [TBL] [Abstract][Full Text] [Related]  

  • 38. COVID-19: Addressing Health Systems Deficits and Peculiarities in the African Region.
    Okonofua F; Eimuhi K; Omonkhua A; Balogun J
    Afr J Reprod Health; 2020 Jun; 24(s1):11-16. PubMed ID: 34077046
    [No Abstract]   [Full Text] [Related]  

  • 39. Functional impact on adults and older people after hospitalization by Covid-19.
    Ochiai GS; de Godoy CG; Silva ÉCGE; de Oliveira DB; da Silva EM; Viana BOC; da Silva JM; de Souza ROB; Dos Santos MD; de Campos CM; Schmitt ACB; de Carvalho CRF; Fu C; Tanaka C; Toufen C; de Carvalho CRR; Pompeu JE
    Physiother Res Int; 2023 Apr; 28(2):e1983. PubMed ID: 36377222
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Infections, hospitalisations, and deaths averted via a nationwide vaccination campaign using the Pfizer-BioNTech BNT162b2 mRNA COVID-19 vaccine in Israel: a retrospective surveillance study.
    Haas EJ; McLaughlin JM; Khan F; Angulo FJ; Anis E; Lipsitch M; Singer SR; Mircus G; Brooks N; Smaja M; Pan K; Southern J; Swerdlow DL; Jodar L; Levy Y; Alroy-Preis S
    Lancet Infect Dis; 2022 Mar; 22(3):357-366. PubMed ID: 34562375
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.